Stratec SE
XETRA:SBS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Stratec SE
Operating Income
Stratec SE
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Stratec SE
XETRA:SBS
|
Operating Income
€28.3m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Carl Zeiss Meditec AG
XETRA:AFX
|
Operating Income
€196.5m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Operating Income
€73.7m
|
CAGR 3-Years
20%
|
CAGR 5-Years
21%
|
CAGR 10-Years
29%
|
|
|
Siemens Healthineers AG
XETRA:SHL
|
Operating Income
€3.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
Operating Income
€231.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-11%
|
CAGR 10-Years
12%
|
|
|
Sartorius AG
XETRA:SRT
|
Operating Income
€559m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
10%
|
|
Stratec SE
Glance View
STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,398 full-time employees. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
See Also
What is Stratec SE's Operating Income?
Operating Income
28.3m
EUR
Based on the financial report for Sep 30, 2025, Stratec SE's Operating Income amounts to 28.3m EUR.
What is Stratec SE's Operating Income growth rate?
Operating Income CAGR 10Y
1%
Over the last year, the Operating Income growth was 48%. The average annual Operating Income growth rates for Stratec SE have been -11% over the past three years , and 1% over the past ten years .
